541 related articles for article (PubMed ID: 31209778)
41. DCE-MRI Radiomics Analysis in Differentiating Luminal A and Luminal B Breast Cancer Molecular Subtypes.
Lafcı O; Celepli P; Seher Öztekin P; Koşar PN
Acad Radiol; 2023 Jan; 30(1):22-29. PubMed ID: 35595629
[TBL] [Abstract][Full Text] [Related]
42. A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer.
Demircioglu A; Grueneisen J; Ingenwerth M; Hoffmann O; Pinker-Domenig K; Morris E; Haubold J; Forsting M; Nensa F; Umutlu L
PLoS One; 2020; 15(6):e0234871. PubMed ID: 32589681
[TBL] [Abstract][Full Text] [Related]
43. Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI.
Kato F; Kudo K; Yamashita H; Wang J; Hosoda M; Hatanaka KC; Mimura R; Oyama-Manabe N; Shirato H
Eur J Radiol; 2016 Jan; 85(1):96-102. PubMed ID: 26724653
[TBL] [Abstract][Full Text] [Related]
44. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
[TBL] [Abstract][Full Text] [Related]
45. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
46. Assessment of Prognostic Factors and Molecular Subtypes of Breast Cancer With a Continuous-Time Random-Walk MR Diffusion Model: Using Whole Tumor Histogram Analysis.
Qin Y; Tang C; Hu Q; Yi J; Yin T; Ai T
J Magn Reson Imaging; 2023 Jul; 58(1):93-105. PubMed ID: 36251468
[TBL] [Abstract][Full Text] [Related]
47. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer.
Durando M; Gennaro L; Cho GY; Giri DD; Gnanasigamani MM; Patil S; Sutton EJ; Deasy JO; Morris EA; Thakur SB
Eur J Radiol; 2016 Sep; 85(9):1651-8. PubMed ID: 27501902
[TBL] [Abstract][Full Text] [Related]
48. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI.
Daimiel Naranjo I; Lo Gullo R; Saccarelli C; Thakur SB; Bitencourt A; Morris EA; Jochelson MS; Sevilimedu V; Martinez DF; Pinker-Domenig K
Eur Radiol; 2021 Jan; 31(1):356-367. PubMed ID: 32780207
[TBL] [Abstract][Full Text] [Related]
50. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
51. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
[TBL] [Abstract][Full Text] [Related]
52. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI.
Niu S; Jiang W; Zhao N; Jiang T; Dong Y; Luo Y; Yu T; Jiang X
J Cancer Res Clin Oncol; 2022 Jan; 148(1):97-106. PubMed ID: 34623517
[TBL] [Abstract][Full Text] [Related]
53. Generative adversarial network-based super-resolution of diffusion-weighted imaging: Application to tumour radiomics in breast cancer.
Fan M; Liu Z; Xu M; Wang S; Zeng T; Gao X; Li L
NMR Biomed; 2020 Aug; 33(8):e4345. PubMed ID: 32521567
[TBL] [Abstract][Full Text] [Related]
54. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
55. Value of magnetic resonance imaging radiomics features in predicting histologic grade of invasive ductal carcinoma of the breast.
Yang XL; Ni DH; Yu Y; Zhao JC; Lin R; Xiu C; Chang ZX
Technol Health Care; 2024; 32(3):1609-1618. PubMed ID: 38393931
[TBL] [Abstract][Full Text] [Related]
56. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
[TBL] [Abstract][Full Text] [Related]
57. Whole-tumor histogram analysis of multiparametric breast magnetic resonance imaging to differentiate pure mucinous breast carcinomas from fibroadenomas with high-signal intensity on T2WI.
Li X; Chai W; Sun K; Zhu H; Yan F
Magn Reson Imaging; 2024 Feb; 106():8-17. PubMed ID: 38035946
[TBL] [Abstract][Full Text] [Related]
58. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
Surov A; Chang YW; Li L; Martincich L; Partridge SC; Kim JY; Wienke A
BMC Cancer; 2019 Nov; 19(1):1043. PubMed ID: 31690273
[TBL] [Abstract][Full Text] [Related]
59. Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI.
Du S; Gao S; Zhang L; Yang X; Qi X; Li S
Magn Reson Imaging; 2021 Apr; 77():148-158. PubMed ID: 33309922
[TBL] [Abstract][Full Text] [Related]
60. Analysis of radiomic features derived from post-contrast T1-weighted images and apparent diffusion coefficient (ADC) maps for breast lesion evaluation: A retrospective study.
Stogiannos N; Bougias H; Georgiadou E; Leandrou S; Papavasileiou P
Radiography (Lond); 2023 Mar; 29(2):355-361. PubMed ID: 36758380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
